Table 1.
Clinical and imaging characteristics | No PH | PH | P-value |
---|---|---|---|
N = 71 | N = 23 | ||
Male,% | 40 (56.3) | 14 (60.9) | 0.8101 |
Age, years | 68.0 (53.0–77.0) | 68.0 (55.0–73.0) | 0.8156 |
NIHSS score at admission | 16.0 (11.0–19.0) | 17.0 (13.0–19.0) | 0.2254 |
Hypertension,% | 44 (62.0) | 14 (60.9) | 0.9247 |
Diabetes mellitus,% | 10 (14.1) | 4 (17.4) | 0.7398 |
Hyperlipidemia,% | 24 (33.8) | 3 (13.0) | 0.0666 |
Atrial fibrillation,% | 19 (27.1) | 3 (13.0) | 0.2581 |
CAD,% | 15 (22.1) | 3 (13.0) | 0.5456 |
Current statin administration,% | 19 (26.8) | 3 (13.0) | 0.2587 |
Stroke mechanism | |||
Cardioembolic stroke,% | 23 (32.4) | 5 (21.7) | 0.1644 |
Large artery disease,% | 20 (28.2) | 12 (52.2) | |
Other type of stroke,% | 10 (14.1) | 1 (4.4) | |
Undetermined Categories,% | 18 (25.4) | 5 (21.7) | |
Time from onset to CT imaging, hours | 5.5 (3.5–7.8) | 6.0 (4.8–11.5) | 0.3011 |
ASPECTS score on NCT | 8.0 (7.0–9.0) | 7.0 (6.0–9.0) | 0.1003 |
HMCAS on NCT, % | 35 (55.6) | 17 (73.9) | 0.1425 |
Collateral Flow Scores | 2.0 (1.0–3.0) | 2.0 (2.0–3.0) | 0.3106 |
DT>2 s, mL | 55.7 (47.0–70.7) | 59.8 (46.2–70.2) | 0.4442 |
DT>4 s, mL | 27.7 (17.0–40.0) | 36.6 (25.3–51.7) | 0.0243* |
DT>6 s, mL | 11.1 (2.2–21.3) | 17.6 (8.1–34.2) | 0.054 |
DT>8 s, mL | 5.1 (0.3–10.1) | 6.7 (2.5–19.9) | 0.0854 |
DT>10 s, mL | 1.6 (0.0–4.6) | 2.2 (0.3–10.6) | 0.1157 |
rCBF < 40%, mL | 16.2 (4.3–23.4) | 16.9 (6.1–30.5) | 0.2132 |
CBV < 2, mL | 17.2 (3.5–32.3) | 21.9 (5.1–32.5) | 0.7447 |
Site of occlusion | |||
ICA, % | 5 (7.0) | 3 (13.0) | 0.2687 |
M1, % | 53 (74.7) | 13 (56.5) | |
ICA &M1, % | 13 (18.3) | 7 (30.4) | |
Successful recanalization (TIMI:2-3) | 57 (80.3) | 19 (82.6) | 0.8053 |
ASPECTS indicates Alberta Stroke Program Early CT Score; CAD, coronary artery disease; CT, computed tomography; HMCAS, hyperdense middle cerebral artery sign; NCT, noncontrast-CT; NIHSS, National Institutes of Health Stroke Scale; DT, delay time; PH, parenchymal hematoma; rCBF, relative cerebral bold flow, CBV, cerebral blood volume; ICA, internal carotid artery; M1, middle cerebral artery; TIMI, thrombolysis in myocardial infarct.
P < 0.05.